Loading clinical trials...
Loading clinical trials...
A Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group, Phase 3, Therapeutic Confirmatory Clinical Trial to Evaluate the Efficacy and Safety of DWP14012 in Patients With Non-erosive Gastroesophageal Reflux Disease
Conditions
Interventions
DWP14012 20mg
DWP14012 40mg
+1 more
Locations
1
South Korea
Wonkwang University Hospital
Iksan, Jeollabuk-do, South Korea
Start Date
August 31, 2023
Primary Completion Date
January 1, 2025
Completion Date
March 1, 2025
Last Updated
November 8, 2023
NCT07174882
NCT07518420
NCT05890001
NCT07041060
NCT02081404
NCT05369884
Lead Sponsor
Daewoong Pharmaceutical Co. LTD.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions